Drug: INFLIXIMAB Injury: Lupus-like syndrome Quarter: 2016Q3
Total Records: 8 Number of Pages: 1
Event ID | DRUGNAME | PT | Drug Manufacturer | Patient Age | Sex | Weight | Date (YYYYMMDD) | Country |
---|---|---|---|---|---|---|---|---|
121618842 | INFLIXIMAB | Lupus-like syndrome | ACCORD | 35.00 YR | F | 0 | 20160806 | GB |
125349181 | INFLIXIMAB | Lupus-like syndrome | ABBVIE | 35.00 YR | F | 0 | 20160707 | GB |
125621961 | Infliximab | Lupus-like syndrome | MEDAC | 35.00 YR | F | 0 | 20160715 | COUNTRY NOT SPECIFIED |
125729271 | INFLIXIMAB | Lupus-like syndrome | ACCORD | 35.00 YR | F | 0 | 20160720 | GB |
125757601 | INFLIXIMAB | Lupus-like syndrome | SANDOZ | 35.00 YR | F | 0 | 20160720 | GB |
125758481 | INFLIXIMAB | Lupus-like syndrome | INTERCHEM | 35.00 YR | F | 0 | 20160720 | GB |
126605171 | Infliximab | Lupus-like syndrome | CELLTRION | 0.00 | 0 | 20160817 | GB | |
127395171 | INFLIXIMAB | Lupus-like syndrome | JANSSEN | 0.00 | 0 | 20160913 | CN |
Total Records: 8 Number of Pages: 1